Skip to main content

Blockade of Interleukin-6 Effects on Cytokine Profiles and Macrophage Activation After Spinal Cord Injury in Mice

  • Chapter
  • First Online:
Book cover Neuroprotection and Regeneration of the Spinal Cord

Abstract

The objective of this study was to clarify the effects of a temporal blockade of IL-6/IL-6 receptor (IL-6R) engagement, using an anti-mouse IL-6R monoclonal antibody (MR16-1), on macrophage activation and the inflammatory response in the acute phase after spinal cord injury (SCI) in mice. MR16-1 antibodies versus isotype control antibodies or saline alone was administered immediately after thoracic SCI in mice. MR16-1-treated group samples showed increased neuronal regeneration and locomotor recovery compared with controls. Immunoblot analysis of the MR16-1-treated samples identified downregulation of Th1 and upregulation of Th2 cytokines. MR16-1 treatment promoted arginase-1-positive, CD206-positive M2 macrophages, with preferential localization of these cells at the injury site and enhanced positivity for Mac-2 and Mac-3, suggestive of increased phagocytic behavior. The results suggest that temporal blockade of IL-6 signaling after SCI abrogates damaging inflammatory activity and promotes functional recovery by promoting the formation of alternatively activated M2 macrophages.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pineau I, Lacroix S et al (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500:267–285

    Article  CAS  PubMed  Google Scholar 

  2. Giger RJ, Hollis ER, Tuszynski MH et al (2010) Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol 2:a001867

    Article  PubMed  Google Scholar 

  3. David S, Bouchard C, Tsatas O et al (1990) Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron 5:463–469

    Article  CAS  PubMed  Google Scholar 

  4. Busch SA, Horn KP, Silver DJ et al (2009) Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci 29:9967–9976

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Gensel JC, Nakamura S, Guan Z et al (2009) Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci 29:3956–3968

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35

    Article  CAS  PubMed  Google Scholar 

  8. David S, Kroner A (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388–399

    Article  CAS  PubMed  Google Scholar 

  9. Kigerl KA, Gensel JC, Ankeny DP et al (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435–13444

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Gruol DL, Nelson TE (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15:307–339

    Article  CAS  PubMed  Google Scholar 

  11. Van Wagoner NJ, Benveniste EN (1999) Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 100:124–139

    Article  PubMed  Google Scholar 

  12. Cafferty WB, Gardiner NJ, Das P et al (2004) Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci 24:4432–4443

    Article  CAS  PubMed  Google Scholar 

  13. Okazaki M, Yamada Y, Nishimoto N et al (2002) Characterization of anti-mouse interleukin-6 receptor antibody. Immunol Lett 84:231–240

    Article  CAS  PubMed  Google Scholar 

  14. Okada S, Nakamura M, Mikami Y et al (2004) Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 76:265–276

    Article  CAS  PubMed  Google Scholar 

  15. Mukaino M, Nakamura M, Yamada O et al (2010) Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 224:403–414

    Article  CAS  PubMed  Google Scholar 

  16. Ponomarev ED, Maresz K, Tan Y et al (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27:10714–10721

    Article  CAS  PubMed  Google Scholar 

  17. Shin WH, Lee DY, Park KW et al (2004) Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 46:142–152

    Article  PubMed  Google Scholar 

  18. Brandt E, Woerly G, Younes AB et al (2000) IL-4 production by human polymorphonuclear neutrophils. J Leukoc Biol 68:125–130

    CAS  PubMed  Google Scholar 

  19. Pouliot P, Turmel V, Gelinas E et al (2005) Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 35:804–810

    Article  CAS  PubMed  Google Scholar 

  20. Tamura T, Udagawa N, Takahashi N et al (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 90:11924–11928

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Rodriguez Guerrero A, Uchida K, Nakajima H et al (2012) Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation 9:40

    Article  Google Scholar 

  22. Kishimoto T, Akira S, Narazaki M et al (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243–1254

    CAS  PubMed  Google Scholar 

  23. Choy EH, Isenberg DA, Garrood T et al (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46:3143–3150

    Article  CAS  PubMed  Google Scholar 

  24. Okano H, Okada S, Nakamura M et al (2005) Neural stem cells and regeneration of injured spinal cord. Kidney Int 68:1927–1931

    Article  CAS  PubMed  Google Scholar 

  25. Ma J, Chen T, Mandelin J et al (2003) Regulation of macrophage activation. Cell Mol Life Sci 60:2334–2346

    Article  CAS  PubMed  Google Scholar 

  26. Stout RD, Jiang C, Matta B et al (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175:342–349

    CAS  PubMed  Google Scholar 

  27. Ethuin F, Gerard B, Benna JE et al (2004) Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab Invest 84:1363–1371

    Article  CAS  PubMed  Google Scholar 

  28. Schwartz M (2010) “Tissue-repairing” blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells? Brain Behav Immun 24(7):1054–1057

    Article  CAS  PubMed  Google Scholar 

  29. Bomstein Y, Marder JB, Vitner K et al (2003) Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol 142:10–16

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

 This work was supported in part by Grants-in-Aid to HN, KU, and HB for General Scientific Research of the Ministry of Education, Science and Culture of Japan (grants numbers B19791023, C21591895, C21791389, B22390287, and B23791631).

Conflict of Interest  All authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenzo Uchida .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Guerrero, A.R. et al. (2014). Blockade of Interleukin-6 Effects on Cytokine Profiles and Macrophage Activation After Spinal Cord Injury in Mice. In: Uchida, K., Nakamura, M., Ozawa, H., Katoh, S., Toyama, Y. (eds) Neuroprotection and Regeneration of the Spinal Cord. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54502-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54502-6_17

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54501-9

  • Online ISBN: 978-4-431-54502-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics